iShares Biotechnology ETF Rating $195.70 0.00 (0.00%) As of 07/2/2026 04:00 PM Eastern Add Compare Share Share Ratings Stock AnalysisChartDividendHeadlinesHoldingsOptions ChainOwnershipRatingsSEC FilingsShort InterestTrendsBuy This Stock iShares Biotechnology ETF Aggregate Rating and Price Target (2026)How MarketBeat Aggregates ETF Rating and Price TargetMarketBeat calculates the aggregate rating and price target for an ETF by considering the weight of each stock in its portfolio. These ratings and price targets are based on the most recent ratings given by Wall Street analysts over the past year. The aggregate rating reviews the ETF's overall performance and is categorized as strong sell, sell, reduce, hold, moderate buy, buy, or strong buy. The aggegreate price target represents the average potential upside for the consensus price target of individual holdings in the ETF.IBB Aggregate RatingModerate Buy 2.72Holdings in IBB have an aggregate rating of Moderate Buy based on 530 analyst ratings issued in the past year covering 25 companies (65.3% of the portfolio).IBB Aggregate Price Target$195.70High Prediction$195.70Average Prediction$195.70Low Prediction$195.70Holdings in IBB have an aggregate price target of $195.70 and a range of $195.70 to $195.70 covering 25 companies (65.3% of the portfolio).IBB Consensus Ratings of HoldingsStrong Buy0 Strong Buy rating(s)Buy2 Buy rating(s)Moderate Buy18 Moderate Buy rating(s)Hold4 Hold rating(s)Reduce1 Reduce rating(s)Sell0 Sell rating(s)Strong Sell0 Strong Sell rating(s) Ratings for Stocks Held by iShares Biotechnology ETF Strong Sell Sell Reduce Hold Moderate Buy Buy Strong Buy Ratings for the Top 25 IBB Holdings ExportWeight In ETFCompanyShare PriceMarketRank™Consensus Rating ScoreConsensus Price TargetPossible UpsideNumber of RatingsIndicator(s)ViewRatings8.01%VRTXVertex Pharmaceuticals$528.043.5581 of 5 stars2.84$555.91 5.3%25Analyst DowngradeInsider TradeGap Down7.95%AMGNAmgen$374.154.032 of 5 stars2.43$355.50 -5.0%30Analyst ForecastGap Down7.30%GILDGilead Sciences$131.274.9686 of 5 stars2.86$158.41 20.7%29Positive NewsInsider TradeAnalyst RevisionGap Down5.23%REGNRegeneron Pharmaceuticals$654.274.8494 of 5 stars2.73$792.65 21.2%26Positive NewsAnalyst DowngradeGap Down3.87%ARGXargenex$939.683.9401 of 5 stars2.92$1,034.56 10.1%24Analyst Forecast3.14%ALNYAlnylam Pharmaceuticals$312.784.2496 of 5 stars2.85$461.39 47.5%26Analyst RevisionGap Down2.68%NTRANatera$279.321.8519 of 5 stars2.86$260.33 -6.8%222.64%RVMDRevolution Medicines$189.241.7151 of 5 stars3.00$135.39 -28.5%22News CoverageAnalyst ForecastInsider Trade2.44%BIIBBiogen$216.123.2577 of 5 stars2.52$217.41 0.6%312.08%ILMNIllumina$188.682.2968 of 5 stars2.32$148.94 -21.1%19Analyst Forecast1.97%MRNAModerna$79.761.1719 of 5 stars1.83$37.13 -53.4%18Gap Down1.87%UTHRUnited Therapeutics$555.914.4943 of 5 stars2.85$619.42 11.4%13Trending NewsInsider Trade1.83%ONCBeOne Medicines$297.654.737 of 5 stars2.93$390.00 31.0%15Analyst Forecast1.75%INSMInsmed$111.603.6273 of 5 stars2.96$211.86 89.8%25Positive News1.65%INCYIncyte$116.863.7967 of 5 stars2.36$107.85 -7.7%22Options VolumeGap Down1.39%ROIVRoivant Sciences$35.131.8376 of 5 stars2.75$33.59 -4.4%12Insider Trade1.33%NBIXNeurocrine Biosciences$174.264.3915 of 5 stars2.96$187.52 7.6%23Insider TradeGap Down1.21%ASNDAscendis Pharma A/S$274.504.1233 of 5 stars3.00$295.39 7.6%19Analyst Upgrade1.12%GMABGenmab A/S$28.514.7889 of 5 stars2.75$38.21 34.0%12Analyst Forecast1.07%EXELExelixis$55.852.2773 of 5 stars2.35$47.60 -14.8%20Analyst ForecastOptions VolumeGap Down1.02%IONSIonis Pharmaceuticals$81.803.0083 of 5 stars2.90$102.90 25.8%21Insider TradeGap Down0.95%BBIOBridgeBio Pharma$77.192.7774 of 5 stars2.83$92.90 20.4%24Gap Down0.93%MDGLMadrigal Pharmaceuticals$528.103.7384 of 5 stars2.78$687.93 30.3%18Gap Down0.92%AXSMAxsome Therapeutics$244.311.9997 of 5 stars2.95$258.95 6.0%21Positive NewsInsider Trade0.92%ARWRArrowhead Pharmaceuticals$83.991.8378 of 5 stars2.69$87.27 3.9%13Analyst ForecastAnalyst RevisionGap Down This page (NASDAQ:IBB) was last updated on 7/4/2026 by MarketBeat.com Staff. From Our PartnersWorld’s Largest Investors Are Moving Their Money (Not Into AI)While headlines focus on the next AI IPO, the world's largest investors are moving capital into one asset at t...Stansberry Research | SponsoredGoldman Sachs: 300 million jobs will disappearGoldman Sachs predicts 300 million jobs will disappear - and Elon Musk's 'Project Apex' AI supercomputer is ac...InvestorPlace | SponsoredTrump's gold order: the announcement they won't put on the front pageOn August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredURGENT Dollar Reset Warning for MondayA 50-year U.S.-Saudi arrangement established under Henry Kissinger - one credited with anchoring the dollar in...Golden Portfolio | SponsoredThe semiconductor stock supplying Apple and SpaceX on fire in 2026A semiconductor company supplying both Apple and SpaceX just doubled its data center revenue forecast to 1 bil...Weiss Ratings | SponsoredYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...Profits Run | Sponsored“By July 30, Elon Musk’s Prophecy Will Fulfill Itself”Jeff Brown and Marc Chaikin - the duo who identified Nvidia a decade ago - are forecasting that Elon Musk's AI...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold is hitting record highs, but most investors are leaving income on the table. A $15 fund is quietly paying...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iShares Biotechnology ETF Please log in to your account or sign up in order to add this asset to your watchlist. Share iShares Biotechnology ETF With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBB Stock Alerts